Evaluation of the Major Steps in the Conventional Protocol for the Alkaline Comet Assay.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Dec 2019
Historique:
received: 23 10 2019
revised: 26 11 2019
accepted: 28 11 2019
entrez: 8 12 2019
pubmed: 8 12 2019
medline: 18 4 2020
Statut: epublish

Résumé

Single cell gel electrophoresis, also known as the comet assay, has become a widespread DNA damage assessment tool due to its sensitivity, adaptability, low cost, ease of use, and reliability. Despite these benefits, this assay has shortcomings, such as long assay running time, the manipulation of multiple slides, individually, through numerous process steps, the challenge of working in a darkened environment, and reportedly considerable inter- and intra-laboratory variation. All researchers typically perform the comet assay based upon a common core approach; however, it appears that some steps in this core have little proven basis, and may exist, partly, out of convenience, or dogma. The aim of this study was to critically re-evaluate key steps in the comet assay, using our laboratory's protocol as a model, firstly to understand the scientific basis for why certain steps in the protocol are performed in a particular manner, and secondly to simplify the assay, and decrease the cost and run time. Here, the shelf life of the lysis and neutralization buffers, the effect of temperature and incubation period during the lysis step, the necessity for drying the slides between the electrophoresis and staining step, and the need to perform the sample workup and electrophoresis steps under subdued light were all evaluated.

Identifiants

pubmed: 31810189
pii: ijms20236072
doi: 10.3390/ijms20236072
pmc: PMC6929057
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIEHS NIH HHS
ID : R41ES030274
Pays : United States

Références

J Photochem Photobiol B. 2005 May 13;79(2):101-8
pubmed: 15878115
Mutagenesis. 2013 May;28(3):333-40
pubmed: 23462850
Mol Biotechnol. 2004 Mar;26(3):249-61
pubmed: 15004294
Cell Biol Toxicol. 2009 Feb;25(1):81-98
pubmed: 17972149
Front Genet. 2015 Jul 10;6:239
pubmed: 26217380
Nat Protoc. 2006;1(1):23-9
pubmed: 17406208
FASEB Bioadv. 2018 Dec 20;1(1):32-39
pubmed: 32123810
Mutat Res. 2011 Sep 18;724(1-2):41-5
pubmed: 21645630
Mutagenesis. 2015 Jan;30(1):21-8
pubmed: 25527724
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10008-13
pubmed: 20534572
Int J Cancer. 2014 Mar 1;134(5):1102-11
pubmed: 23959905
J Clin Diagn Res. 2015 Mar;9(3):GE01-5
pubmed: 25954633
Br J Cancer. 1998 Apr;77(7):1108-14
pubmed: 9569047
Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:27-39
pubmed: 24184488
Reprod Biomed Online. 2009 May;18(5):609-16
pubmed: 19549437
Clin Exp Med. 2006 Dec;6(4):177-90
pubmed: 17191110
Sci Rep. 2014 Nov 26;4:7200
pubmed: 25425241
Mutat Res Genet Toxicol Environ Mutagen. 2019 Jul;843:24-32
pubmed: 31421734
Food Chem Toxicol. 2018 Jun;116(Pt B):379-387
pubmed: 29689355
Appl Theor Electrophor. 1989;1(2):109-13
pubmed: 2488589
Mutat Res. 1996 Sep 13;370(2):115-20
pubmed: 8879269
Int J Radiat Biol. 1998 Jun;73(6):649-60
pubmed: 9690683
Redox Biol. 2014 Jan 09;2:457-65
pubmed: 24624335
J Natl Cancer Inst. 2003 Apr 2;95(7):540-7
pubmed: 12671022
Front Genet. 2015 Aug 13;6:266
pubmed: 26322077
ACS Nano. 2014 Mar 25;8(3):2118-33
pubmed: 24617523
Mutagenesis. 2008 May;23(3):143-51
pubmed: 18283046
Adv Exp Med Biol. 2017;1026:105-123
pubmed: 29282681
Wien Klin Wochenschr. 2011 Dec;123(23-24):693-9
pubmed: 22024999
Ecotoxicology. 2005 Apr;14(3):323-35
pubmed: 15943108
Mutat Res. 2009 Jan-Feb;681(1):80-92
pubmed: 18439870
Clin Exp Med. 2010 Jun;10(2):87-92
pubmed: 19902326
J Urol. 2003 Jun;169(6):1983-92
pubmed: 12771703
Mutagenesis. 2017 May 1;32(3):397-408
pubmed: 28340065
Mutagenesis. 2018 Feb 24;33(1):1-7
pubmed: 29325088
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):
pubmed: 23378590
Methods Mol Biol. 2002;203:179-94
pubmed: 12073441
Mutat Res. 2009 Jan-Feb;681(1):93-109
pubmed: 19056514
Mutagenesis. 2015 Jan;30(1):1-4
pubmed: 25527721
Sci Rep. 2016 Sep 01;6:32162
pubmed: 27581626
Mutagenesis. 2008 May;23(3):183-90
pubmed: 18256034
Environ Mol Mutagen. 2000;35(3):206-21
pubmed: 10737956
Radiat Res Suppl. 1985;8:S103-11
pubmed: 3867077
Br J Cancer. 2003 Dec 15;89(12):2271-6
pubmed: 14676805
Mutat Res. 2007 Jun 15;630(1-2):122-8
pubmed: 17509930

Auteurs

Mahsa Karbaschi (M)

Oxidative Stress Group, Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.
Department of Human and Molecular Genetics, Florida International University, Miami, FL 33199, USA.

Yunhee Ji (Y)

Oxidative Stress Group, Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.

Abdulhadi Mohammed S Abdulwahed (AMS)

Oxidative Stress Group, Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.

Alhanoof Alohaly (A)

Department of Dietetics and Nutrition, Florida International University, Miami, FL 33199, USA.

Juan F Bedoya (JF)

Oxidative Stress Group, Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.

Shanna L Burke (SL)

School of Social Work, Florida International University, Miami, FL 33199, USA.

Thomas M Boulos (TM)

Oxidative Stress Group, Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.

Helen G Tempest (HG)

Department of Human and Molecular Genetics, Florida International University, Miami, FL 33199, USA.
Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, USA.

Marcus S Cooke (MS)

Oxidative Stress Group, Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.
Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH